🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single dose, crossover study to assess the abuse potential of TC-...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01500018
Treatments Being Tested
The primary objective of this study is to describe the single- and multiple...
Status
Completed
Location
VIVUS, Inc.
Start Date
2007-07
Trial ID
NCT00518466
Treatments Being Tested
This study will demonstrate the efficacy of Qsymia versus placebo in treati...
Status
Completed
Location
Stanford School of Medicine, Psychiatry and Behavioral Sciences
Start Date
2015-10-30
Trial ID
NCT02553824
Treatments Being Tested
This study will compare the effect of orforglipron and phentermine on weigh...
Status
Not Yet Recruiting
Location
Massachusetts General Hospital
Start Date
2026-11-01
Trial ID
NCT07729332
Treatments Being Tested
The purpose of this study is to treat toddler obesity by improving the todd...
Status
Withdrawn
Location
Loma Linda University
Start Date
2025-12
Trial ID
NCT06768320
Treatments Being Tested
The purpose of this research study is to understand the long-term effects o...
Status
Active Not Recruiting
Location
Kaiser Permanente Southern California
Start Date
2022-06-30
Trial ID
NCT05176626
Treatments Being Tested
PhITT is a Phase IIb, multicenter, randomized, double-blind, placebo-contro...
Status
Recruiting
Location
Pennington Biomedical Research Center
Start Date
2026-06-03
Trial ID
NCT07282340
Treatments Being Tested
This study will assess the feasibility to assess practicality of early weig...
Status
Withdrawn
Location
Stanford University
Start Date
2022-06-01
Trial ID
NCT04572217
Treatments Being Tested
The study is being conducted to evaluate the effect of VI-0521 (Qsymia®) on...
Status
Completed
Location
Clinical Site
Start Date
2022-01-25
Trial ID
NCT05215418
Treatments Being Tested